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A mutant (P1-616) of the tobacco vein mottling potyvirus that contains a four-codon insertion in the P1 protein coding
region of the viral RNA is unable to infect the normal host plant of the virus. Processing of the P1/HC-Pro cleavage site does
not occur during in vitro translation of the mutant viral RNA. When plants transformed with the P1/HC-Pro/P3 coding region
of tobacco vein mottling potyvirus RNA were inoculated with P1-616, some of them became infected, although there was a
delay in the production of disease symptoms. Virus isolated from these plants was able to infect nontransgenic plants. Two
variants of the recovered, infectious virus contained single-nucleotide alterations in the four-codon insertion in the P1-616
genome. In vitro translation of the variant genomic RNAs resulted in partial processing of the P1/HC-Pro cleavage site,
although serological analysis of infected tissue showed complete processing in vivo. These results indicate that limited
complementation of P1-616 occurs in the transgenic plants and that eventually there arises one or more variants of the
mutant sequence that can effect P1/HC-Pro processing and therefore be replicated. © 1999 Academic Pressc
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Members of the Potyvirus genus of plant viruses have
ositive-strand RNA genomes and are included in the
icornavirus-like supergroup of viruses. The genomic
NA of the potyviruses contains a single open reading
rame whose translation product is processed by three
irus-encoded proteinases to yield the mature viral pro-
eins (Lindbo and Dougherty, 1994). Two proteins con-
ained in the N-terminal part of the potyviral polyprotein
ave proteinase activities that catalyze autoproteolytic
leavages. The P1 protein is a serine-type protease de-
ived from the N-terminus of the polyprotein through
leavage of a Tyr-Ser dipeptide representing the C-ter-
inus of P1 and the N-terminus of the protein HC-Pro
Mavankal and Rhoads, 1991; Verchot et al., 1991, 1992).
C-Pro is a cysteine-type protease that cleaves at a
ly-Gly dipeptide to define its own C-terminus and the
-terminus of the P3 protein (Carrington et al., 1989; Oh
nd Carrington, 1989). P1 and HC-Pro are multifunctional
roteins, and the domains involved in proteolysis are
ocated in the C-terminal halves of the two proteins (Oh
nd Carrington, 1989; Verchot et al., 1992).
Additional nonproteolytic functions have been as-
igned to both P1 and HC-Pro. The P1 protein has an
ccessory role in potyvirus genome amplification that
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854506. E-mail: erguez@cnb.uam.es.042-6822/99 $30.00
opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
322an be complemented in trans in cells expressing trans-
enic P1 protein (Verchot and Carrington, 1995b); it also
as the ability to bind single-stranded RNA nonselec-
ively in vitro (Brantley and Hunt, 1993). These nonpro-
eolytic functional domains of P1 have not been mapped
recisely. Several important functions have been
apped to specific domains of HC-Pro (Kasschau et al.,
997; Maia et al., 1996); these include the acquisition and
ransmission of virus by aphids, the accumulation of
rogeny viral RNA, and systemic movement of virus
hrough the vascular tissue of the plant (Atreya et al.,
992; Kasschau et al., 1997). The P1 and HC-Pro proteins
an act as pathogenicity enhancers of several heterolo-
ous plant viruses, probably as trans-activators of viral
eplication (Pruss et al., 1997; Shi et al., 1997). Recent
tudies indicate that the P1/HC-Pro coding region of a
otyvirus is a general supressor of posttranscriptional
ene silencing in plants (Anandalakshmi et al., 1998;
asschau and Carrington, 1998). This finding could ex-
lain the previously mentioned roles of HC-Pro in pro-
onging potyvirus genome amplification and heterolo-
ous virus accumulation.
Although deletion of the entire P1 coding sequence,
hich substantially reduces genome amplification, does
ot completely abolish the infectivity of tobacco etch
irus (TEV) modified to express GUS (Verchot and Car-
ington, 1995b), minor mutations that impair P1 proteo-
ytic activity in vitro render TEV-GUS nonviable (Verchot
nd Carrington, 1995a). The separation of P1 from HC-
ro, rather than the intrinsic P1 proteolytic activity, seems
o be essential for infectivity with the TEV-GUS system
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323RESCUE OF TVMV FROM TRANSGENIC PLANTSVerchot and Carrington, 1995b), suggesting that a P1/
C-Pro polyprotein is unable to carry out all the functions
erformed by the mature proteins. With an unmodified
otyvirus, tobacco vein mottling virus (TVMV), a series of
2-nucleotide (nt) insertion mutants have been con-
tructed and characterized (Klein et al., 1994). Mutant
1-616 is nonviable (i.e., unable to produce detectable
mounts of progeny viral RNA in inoculated protoplasts
r plants). In this study, the effect of the P1-616 mutation
n TVMV P1 proteinase activity in vitro was analyzed. The
bility of mutant P1-616 to be rescued in transgenic
lants that express the P1, HC-Pro, and P3 coding re-
ions of TVMV RNA also was investigated.
RESULTS
onviable mutant P1-616 is defective in P1
roteinase activity in vitro
The P1 protein of TVMV mutant P1-616 contains a
er-Arg-Asp-Arg insertion between amino acid residues
55/156 that renders it noninfectious in tobacco proto-
lasts or plants (Klein et al., 1994). The effect of this
nsertion in the proteolytic function of the P1 protein was
tudied by in vitro translation in the wheat germ extract
ystem because the P1 proteinase is not functional in a
abbit reticulocyte lysate (Mavankal and Rhoads, 1991;
erchot et al., 1991). The main products of translation of
ull-length TVMV RNA in the wheat germ system (Fig. 1,
ane 1) are P1, HC-Pro, and the p75 precursor generated
y incomplete processing of the P1/HC-Pro junction in
he in vitro system (Mavankal and Rhoads, 1991). Trans-
ation of mutant P1-616 (Fig. 1, lane 2) shows accumula-
FIG. 1. Analysis of in vitro P1 proteinase activity in the nonviable
VMV mutant P1-616. Wild-type (lane 1) and P1-616 (lane 2) RNAs were
ynthesized in vitro and translated in the wheat germ system. [35S]Me-
hionine-labeled translation products were analyzed by SDS–PAGE and
luorography. The top band in each lane is at the position expected for
he P1/HC-Pro polyprotein (p75), and the bands at ;50 and ;34 kDa
re those expected for the HC-Pro and P1 proteins, respectively. The
ositions of molecular mass markers (in kDa) are indicated at the left.ion of the p75 precursor but no accumulation of the P1
rotein, indicating a defect in P1 proteinase activity. The
etection of the p75 translation product in P1-616 reac-
ions indicates that the defect in P1 proteinase activity
oes not prevent the HC-Pro proteinase activity; thus the
n vitro translation results indicate that the nonviable
1-616 mutant cannot produce mature P1 or HC-Pro
roteins.
noculation of P1-616 mutant in transgenic plants
To determine whether the replication defect of P1-
16 could be complemented in trans, we inoculated in
itro synthesized RNA transcripts in transgenic to-
acco plants (B8) that were designed to express the
1/HC-Pro/P3 coding region of the genome of TVMV. A
imilar transgene introduced previously in Xanthi to-
acco plants resulted in expression of HC-Pro that
as biologically active (Berger et al., 1989). Western
lot analysis of extracts from transgenic B8 plants
sing anti-HC-Pro serum revealed the presence of a
rotein of the same size as authentic HC-Pro that was
bsent in vector-transformed control plants (Fig. 2).
he level of HC-Pro expressed in B8 plants was 5–10%
f that observed in a typical TVMV-infected plant (Fig.
). Detection of mature HC-Pro in B8 plants indicated
hat P1 and HC-Pro proteinase activities were active in
he B8 transgenic plants and suggested that in addi-
ion to HC-Pro, polypeptides with the size of P1 and P3
roteins should be produced in B8 tobacco cells. How-
ver, Western blot analyses of B8 extracts with anti-
era specific for TVMV P1 or P3 proteins failed to
etect these products in B8 plants (not shown). Be-
ause the P1, HC-Pro, and P3 proteins should be
roduced in equimolar amounts, it could be that P1
FIG. 2. Expression of HC-Pro in the transgenic tobacco line B8 that
ontains a transgene representing the 59 untranslated region and the
1/HC-Pro/P3 coding regions of the TVMV genome. Expression of
ature-size HC-Pro (;50 kDa apparent mobility) was analyzed by
estern blot with anti-TVMV HC-Pro serum. Lane 1 represents extract
rom TVMV-infected tobacco leaves of control line IDK; lane 2, extract
rom noninfected tobacco leaves of control line IDK; and lane 3, extract
rom a representative transgenic plant from line B8. The positions of
olecular mass markers (kDa) are indicated at the left.
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324 MORENO ET AL.nd P3 are not stable in the transgenic plant or that the
iters of the antisera are not sufficient to detect them.
Transgenic B8 plants inoculated with TVMV tran-
cripts (XBS7) showed initial systemic vein-clearing
ymptoms around 7 days postinoculation (p.i.) and had a
igh titer of virus estimated by ELISA at 2 weeks p.i. After
noculation with in vitro transcribed RNA from mutant
1-616, symptoms were observed in a few B8 transgenic
lants (Table 1), but they appeared 2 weeks later than
hose induced by XBS7 transcripts. The P1-616-infected
ransgenic plants had no virus at 2 weeks p.i., as indi-
ated by ELISA, but reached virus titers at 4 weeks p.i.
imilar to those reached by XBS7-inoculated plants (not
FIG. 3. Map of the TVMV genome and nucleotide sequences of cDN
nd in the viable progeny viruses B8R1 and B8R2 (which were obtaine
utant P1-616 has a four-codon insertion at position 616. Infectious v
nsertion (boxed residues) that resulted in the substitution of an Asp resi
ites (underlined) are indicated for each mutant.
TABLE 1
Analysis of Transgenic Plants Inoculated with Wild-Type TVMV
(XBS7) or TVMV Mutant P1-616
P1/HC-Pro/P3-
expressing plantsa
Control plants (line IDK)
P1-616XBS7 (wt) P1-616
xperiment 1 10/10b 2/10 0/10
xperiment 2 10/10 2/10 0/10
xperiment 3 10/16 3/97 0/46
xperiment 4 12/16 3/97 —
a Experiments 1–3 were performed with B8 transgenic plants, and
xperiment 4 was performed with B35 transgenic plants.
b Results expressed as number of infected/number of inoculated
lants as estimated by ELISA at 4 weeks p.i.hown). Vector-transformed tobacco plants (IDK line)
sed as controls were not infected after inoculation with
1-616 transcripts.
Nontransgenic tobacco plants were inoculated with
ap obtained from symptomatic leaves of B8 transgenic
lants that had been inoculated with mutant P1-616. All
ontransgenic tobacco plants developed symptoms of
he same type and at the same time as plants inoculated
ith sap from TVMV-infected plants. This suggested that
nfection of B8 plants by P1-616 was not merely due to
omplementation and that progeny virus from transgenic
lants was genetically different from the defective P1-616
noculum.
equence analysis of progeny virus derived from
ransgenic plants
Virions were purified from one P1-616-infected B8
ransgenic plant 6 weeks p.i. Direct RNA sequencing of
he region surrounding TVMV RNA residue 616 showed
hat the four-codon insertion was maintained in the prog-
ny P1-616 viral RNA but that the third codon, GAU (Asp),
ad been changed by point mutation to either UAU (Tyr)
r GUU (Val). Examination of the RNA sequence autora-
iograms indicated that the virus population contained a
ixture of RNA molecules in each, of which one of the
wo single-nt changes was present (data not shown).
To further identify mutations present in the infec-
ious variants of P1-616 generated in transgenic
lants, we extracted total RNA from two nontransgenic
obacco plants that had been inoculated with progeny
s surrounding TVMV RNA residue 616 in the nonviable mutant P1-616
gh inoculation of B8 transgenic plants with mutant P1-616). Nonviable
B8R1 and B8R2 contain single-nt changes in the third codon of the
a Tyr or Val residue, respectively. The positions of diagnostic restrictionA clone
d throu
ariants
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325RESCUE OF TVMV FROM TRANSGENIC PLANTSirus from P1-616-inoculated B8 transgenic plants. The
omplete P1 coding region of TVMV (nt 154–975) was
mplified by RT-PCR from total RNA extracts and
loned to obtain plasmids pB8R1 and pB8R2. Se-
uence analysis (Fig. 3) of five clones from each plas-
id revealed that each group of clones was identical
n sequence and that each plant contained one of the
equence variants detected as a mixture in the origi-
al transgenic plant. All clones from plasmid pB8R1
ontained the 12-nt insertion with the UAU (Tyr) codon
n third position, and all pB8R2 plasmids contained the
UU (Val) codon in the equivalent position. In addition
o these changes, there were some nt changes in the
1 coding region of the variants derived from P1-616
noculation of transgenic plants compared with the
nfectious clone pXBS7. These changes included a
ilent mutation in one group of clones and a nonsilent
utation in the other group of clones (not shown).
xperiments described below indicate that these ad-
itional changes were not responsible for the recovery
f virus viability.
Two additional experiments were performed with
1-616 to try to generate more infectious variants by
noculating B8 or B35 transgenic plants. Again, a few
ransgenic plants inoculated with P1-616 became in-
ected (experiments 3 and 4; Table 1), although a
esser proportion of plants inoculated with either P1-
16 or XBS7 transcripts became infected in these later
xperiments. Sap from symptomatic B8 or B35 trans-
enic plants was used to inoculate nontransgenic to-
acco plants, and virus isolated from the plants was
nalyzed by direct sequencing of the RT-PCR product
urrounding position 616 in the viral RNA. Wild-type
VMV sequence (i.e., lacking the 12-nt insertion) was
bserved in the three infected plants derived in exper-
ment 3. Symptoms in these transgenic plants ap-
eared after a delay similar to that observed in exper-
ments 1 and 2 (Table 1). In experiment 4, two infected
lants contained virus with the B8R1 variant sequence
Fig. 3), and one plant contained virus with the wild-
ype sequence.
ucleotide changes involved in restoring infectivity of
1-616
The possibility was tested that the point mutations
n the 12-nt insertion of P1-616 observed in plasmids
B8R1 and pB8R2 were sufficient to restore the infec-
ivity of mutant P1-616. We introduced the 12-nt inser-
ion variants found in pB8R1 and pB8R2 (as well as the
riginal 12-nt insertion of P1-616) into mutant P1-616 by
xchanging a restriction fragment (BstXI–AatII) corre-
ponding to residues 341–716. In this way, we gener-
ted plasmids pTVMV-B8R1 and pTVMV-B8R2 and re-
reated pP1-616. Transcription in vitro of plasmids
TVMV-B8R1 and pTVMV-B8R2 produced RNAs thatere infectious in nontransgenic tobacco plants (all of
0 plants were infected), inducing symptoms identical
o those of TVMV in character and time of appearance.
NA transcribed from the recreated P1-616 clone was
ot infectious. Progeny viruses TVMV-B8R1 and TVMV-
8R2 were purified, and the encapsidated RNA was
xtracted and analyzed by direct sequencing. The re-
ults confirmed that each progeny viral RNA retained
ts specific 12-nt insertion (not shown). Thus the single
t changes generated in transgenic plants in the 12-nt
nsertion of mutant P1-616 were sufficient for restora-
ion of viability of the virus. The infectivity of purified
irions of the infectious variants TVMV-B8R1 and
VMV-B8R2 in tobacco plants was comparable to that
f wild-type TVMV (Table 2).
1 proteinase activity of infectious variants TVMV-
8R1 and TVMV-B8R2
To determine whether restoration of infectivity by a
oint mutation in the P1-616 mutant was associated with
he ability of the mutant P1 proteinase to cleave at the
1/HC-Pro junction in vivo, immunoblots of extracts from
BS7-, TVMV-B8R1-, and TVMV-B8R2-infected tobacco
eaves were probed with antiserum specific for TVMV P1
rotein. A band with a mobility expected for P1 (;34 kDa)
as detected in all cases (Fig. 4A), indicating that the
1/HC-Pro cleavage site was processed in vivo. In fact,
he P1 protein appeared to have slightly lower mobility in
he case of extracts from TVMV-B8R1- and TVMV-B8R2-
nfected plants, possibly reflecting the effect of the four-
odon insertion in the P1 coding region of these viruses.
he extracts were then analyzed for the presence of
C-Pro (Fig. 4B). Expression of a protein of the same size
s native HC-Pro was detected in TVMV-B8R1 and
VMV-B8R2 extracts, confirming the complete process-
ng of the P1/HC-Pro junction by the mutant P1 protein-
ses in vivo and the absence of effects on HC-Pro pro-
einase activity.
The proteolytic activity of the mutant P1 proteinases of
VMV-B8R1 and TVMV-B8R2 was compared with the
ctivity of native P1 proteinase in the wheat germ trans-
TABLE 2
Infectivity in Non-Transgenic Tobacco Plants of Reconstructed
B8R1 and B8R2 Variants of TVMV
Inoculum concentration
(mg/ml)a Control TVMV TVMV-B8R1 TVMV-B8R2
50 8/8b 6/6 6/6
5 7/8 4/6 7/8
0.5 5/8 4/9 5/8
0.05 0/8 3/7 2/7
a Inoculum was purified virus diluted in 50 mM Tris-HCl (pH 7.0).
b Number of infected/number of inoculated plants estimated by
LISA.
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326 MORENO ET AL.ation system. In these experiments, both in vitro-tran-
cribed RNA from pTVMV-B8R1 and pTVMV-B8R2 and
NA extracted from the progeny viruses were used. The
esults using RNA transcripts showed that the mutant P1
roteinases were much less efficient than the native P1
rotein in processing the P1/HC-Pro junction in the
heat germ system (Fig. 5). Compared with the nonvia-
le P1-616 mutant, the P1 proteinases of TVMV-B8R1 and
VMV-B8R2 produced very low amounts of a protein with
he mobility of the mutant P1 protein. The results indicate
hat although the P1 proteinases of TVMV-B8R1 and
VMV-B8R2 are fully functional in vivo, their characteris-
ics make them very inefficient in the wheat germ trans-
ation system. Similar results were obtained when the
emplates for in vitro translation reactions consisted of
NA purified from progeny viruses TVMV-B8R1 and
VMV-B8R2 (not shown), indicating that passage in a
FIG. 4. Accumulation of P1 and HC-Pro-related products in plants in
xtracts from tobacco leaves probed with antiserum specific for the P1
lants infected with TVMV (lane 2), TVMV-B8R1 (lane 3), and TVMV-B8R
lot probed with antiserum specific for the HC-Pro protein of TVMV. Ex
), TVMV-B8R2 (lane 3), and noninfected control (lane 4).
FIG. 5. Analysis of mutant P1 proteinases by in vitro translation in the
heat germ system. [35S]Methionine-labeled translation products were
nalyzed by SDS–PAGE and fluorography. The reactions contained
NA transcripts XBS7 (lane 1), P1-616 (lane 2), TVMV-B8R1 (lane 3), or
VMV-B8R2 (lane 4). The positions of the very low, but detectable,
mounts of mature P1 protein produced by the B8R1 and B8R2 RNAs
re indicated by the arrow.ontransgenic plant did not modify the efficiency of the
utant P1 proteinases in vitro.
noculation of P1-616 in transgenic plants expressing
he P1 or HC-Pro coding regions alone
The possibility that inoculation with P1-616 will gener-
te infectious variants only in plants simultaneously ex-
ressing both P1 and HC-Pro proteins was considered.
1-616 was used for the inoculation of a number of
vailable transgenic lines that had been transformed
ndividually with the P1 or HC-Pro coding regions of
VMV. None of more than 1 hundred plants of two inde-
endent P1 transgenic lines (P1–9 and P1–52) became
nfected after inoculation with mutant P1-616 (not shown).
owever, these lines had very low levels of transgene
xpression and showed a delayed resistance when in-
culated with TVMV, suggesting that the transgene was
ilenced (Moreno et al., 1998). A similar phenotype of
ery low transgene expression and delayed resistance to
VMV (not shown) was observed in three independent
C-Pro transgenic lines. No HC-Pro was detected by
mmunoblotting in extracts of these plants (not shown),
nd as expected, no plants became infected after being
noculated with P1-616.
DISCUSSION
The insertion of a 12-nt sequence in the P1 coding
egion of TVMV RNA was originally considered to be a
ethal mutation because mutant P1-616 was unable to
nfect the host of the wild-type virus (Klein et al., 1994).
he presence of a sequence alteration in the part of the
1 protein that exhibits proteinase activity and the lack of
roduction of the mature P1 and HC-Pro proteins in in
itro translations programmed with P1-616 transcript
with the B8R1 and B8R2 variants of TVMV. (A) Western blot of protein
of TVMV. Extracts are from noninfected control plant (lane 1) and from
4). A nonspecific band of ;45 kDa is present in all lanes. (B) Western
orresponded to plants infected with TVMV (lane 1), TVMV-B8R1 (lanefected
protein
2 (lane
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327RESCUE OF TVMV FROM TRANSGENIC PLANTSNA pointed to lack of processing of the P1/HC-Pro
leavage site as the reason for the lack of infectivity of
he mutant. The presence of the uncleaved P1-HC-Pro
recursor apparently was not sufficient for the establish-
ent of infection. These results are compatible with
hose obtained in studies of the P1 protein of TEV (Ver-
hot and Carrington, 1995a) and, because it has been
eported that mutants of TEV RNA that lack the entire P1
oding region are able to infect plants (Verchot and
arrington, 1995b), indicate that the critical event in pro-
essing of the N-terminal part of the potyviral polyprotein
s the production of the mature HC-Pro protein.
In none of many experiments has mutant P1-616 pro-
uced infections in nontransgenic plants or in transgenic
ines that do not accumulate viral proteins. However,
hen the possibility was tested that the mutant might
ndergo recombination or complementation events in
ransgenic plants expressing the P1/HC-Pro/P3 coding
egion of the viral genome, it was found that variant
orms of the mutant could be “rescued” from such plants.
he most likely explanation of these results involves
imited complementation of the nonviable mutant by the
ransgene or transgenes, followed by selection from the
rogeny of one or more infectious variants capable of
utcompeting the recipient or recipients of the comple-
entation event. In our system, the variants were shown
o be as infectious as the wild-type virus and required a
ingle-nt change from the incoming genome to restore
nfectivity. Such a process would occur fairly rapidly
ecause there is only a 2-week delay in the full expres-
ion of systemic symptoms in the mutant-inoculated
lants. A similar phenomenon involving “rescue” of infec-
ious virus with second-site mutations from a transgenic
lant inoculated with a tobacco mosaic virus mutant that
s disfunctional in the movement protein gene has been
eported recently (Deom and He, 1997). In this example,
he infectivity of the virus recovered was lower than that
f the wild-type virus. The infectivity of the variants “res-
ued” from transgenic plants is probably influenced by
he nature of the mutation introduced initially, but it could
lso be related with the complementation ability of the
ransgene used. Presumably for transgenic proteins with
fficient activity in trans, the pressure on selection of
nfectious variants would be relaxed and the host would
e capable of sustaining nonviable genomes.
In some experiments, wild-type virus was produced in
few B35 transgenic plants that had been inoculated
ith mutant P1-616. The use of control plants argued
gainst the possibility that these were the result of ac-
idental inoculation. These forms could have arisen by
ecombination, as has been reported with other plant
iruses in transgenic plants (Allison et al., 1996). How-
ver, this would likely require two recombination events
ue to the presence in the transgenic plants of the
9-leader sequence of an unrelated viral RNA upstream
rom the P1/HC-Pro/P3 coding regions. More reasonableould be that the 12-nt insertion was deleted after
omplementation and a few rounds of replication.
If the “rescue” of infectious virus phenomenon de-
cribed here can be accounted for by complementation,
here arises the question of the mechanism by which
uch activity might occur. One possibility would involve
leavage in trans by the transgenically expressed P1
roteinase of a sufficient number of P1/HC-Pro sites to
ermit a low level of replication of the mutant viral RNA
nd the eventual production of a variant of the RNA to
ccur. However, the P1 proteinase of TEV has been
hown to be incapable of processing in trans the P1/HC-
ro junction of mutant constructs in vitro (Verchot et al.,
992). Alternatively, the P1 protein may be incapable of
ediating the cleavage of P1/HC-Pro sites in trans, and
urvival of the mutant RNA before the emergence of a
eplication-competent variant may depend on the avail-
bility of the transgenically expressed P1 and HC-Pro
roteins for functions that enhance genome amplifica-
ion, such as supression of host responses based on
ost-transcriptional gene silencing (Anandalakshmi et
l., 1998; Kasschau and Carrington, 1998). Transgenic
lants that express high levels of P1 or HC-Pro singly
ould be useful in revealing which of these complemen-
ation mechanisms may occur, but as noted, plants that
ould be suitable for such experiments have not yet
een produced. The rescue of a P1 proteinase-inactivat-
ng mutant (S256A) of TEV in transgenic plants express-
ng P1 and HC-Pro (Verchot and Carrington, 1995b) may
ave involved a situation similar to that described here,
ut the report of the phenomenon did not address the
ossibility that the rescued virus might have been capa-
le of infecting nontransgenic plants as the result of
econd-site mutations in the transgenic plants. Never-
heless, the demonstration with mutants of TEV that the
1 protein (Verchot and Carrington, 1995b) and the HC-
ro protein (Kasschau et al., 1997) can function in trans in
erforming their genome-amplification functions would
ppear to favor the second of the above complementa-
ion mechanisms.
As described, single-nt sequence changes in the P1
oding region in the two variants of TVMV mutant P1-616
hat were recovered from transgenic plants were suffi-
ient to produce viral RNA that, unlike that of the mutant,
as capable of infecting nontransgenic plants. In both
ariants, the sequence changes affected the same
mino acid residue and converted it from a negatively
harged to a charged neutral residue. The sequence
hanges in the P1-616 proteinase conferred only very
imited proteolytic activity in vitro but were sufficient to
ully process the P1-HCPro junctions in infections in
lanta. It will be of interest to examine the effect of these
equence alterations on the reported RNA-binding activ-
ties of the P1 protein of TVMV (Brantley and Hunt, 1993)
nd on the folding of the P1 protein when structural
nalyses of the protein are undertaken.
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lasmids
Plasmid pXBS7 (Domier et al., 1989) contains a full-
ength cDNA copy of the TVMV genome cloned down-
tream from a T7 transcription promoter sequence from
hich infectious transcripts (XBS7) can be synthetized.
lasmid pP1-616 is one of a series of four-codon inser-
ion mutants of pXBS7 constructed by Klein et al. (1994).
ransgenic plants
The transgenic tobacco line B8 results from the trans-
ormation of Nicotiana tabacum L. (cv BY21) with a trans-
ene containing the TVMV 59 leader sequence and the
1, HC-Pro, and P3 coding regions. The transgene was
loned in the plant transformation vector pKYLX71, which
ontains a 35S promoter and a rbcS 39 polyadenylation
ite. Details on transgene construction have been re-
orted by Berger et al. (1989). A similar transgene con-
aining the alfalfa mosaic virus (AlMV) RNA 4 leader
equence instead of the TVMV leader was cloned in
KYLX71–35S2, a derivative of pKYLX71 with a dupli-
ated enhancer in the 35S promoter (Maiti et al., 1993).
ransformation of BY21 tobacco plants with this vector
enerated the B35 transgenic line.
Transgenic tobacco lines P1–52 and P1–9 are some of
number of lines that contain the AlMV leader and most
f the P1 coding region (Moreno et al., 1998). Lines
C-18, HC-24, and HC-39 are transgenic tobacco lines
ransformed with the complete TVMV HC-Pro coding
egion downstream from the AlMV leader sequence.
obacco plants (cv. BY21) transformed with pKYLX71–
5S2 (line IDK) were used as controls in all inoculation
xperiments.
n vitro translation reactions
SacI-linearized plasmids were transcribed in vitro as
escribed by Rodrı´guez-Cerezo et al. (1991), and reaction
roducts were subjected to electrophoresis in agarose
els and quantified spectrophotometrically. Wheat germ
xtract (Promega, Madison, WI) translations were per-
ormed according to the manufacturer9s instructions with
35S]methionine using final concentrations of 120 mg/ml
NA and 75 mM potassium acetate. Translation reaction
roducts (5 ml) were analyzed in SDS–polyacrylamide
els. Gels were stained with Coomassie blue, soaked in
mplify (Amersham), dried, and exposed to x-ray film at
80°C.
n vitro transcription and inoculation of plants
Transcripts were synthesized in vitro with T7 RNA
olymerase and SacI-linearized plasmid templates and
sed to inoculate plants as described by Rodrı´guez-
erezo et al. (1991). Plants were monitored daily for
ymptom development and tested by DAS-ELISA usingnti-TVMV coat protein serum 2 and 4 weeks p.i. as
escribed by Klein et al. (1994). Samples analyzed by
LISA were collected from the fourth and sixth leaves
bove the inoculated leaves.
xtraction, sequencing, and cloning of progeny viral
NA from transgenic plants
TVMV was purified from tobacco leaves as described
Murphy et al., 1990), and viral genomic RNA was ex-
racted from virions. Part of the P1 coding region of TVMV
as sequenced directly from purified viral genomic RNA
ith reverse transcriptase (Fichot and Girard, 1990) us-
ng the oligonucleotide primer 59-CGTCAATGAACAAG-
CTC-39 complementary to TVMV RNA residues 677–
94. TVMV nt and amino acid sequence coordinates
orrespond to those in EMBL accession no. X04083,
hich is a corrected version of the sequence originally
eported by Domier et al. (1986).
To clone TVMV RNA sequence variants present in
ransgenic plants, the complete P1 coding region was
mplified by RT-PCR treatment of total RNA preparations
rom tobacco leaf tissue prepared as described previ-
usly (Klein et al., 1994). A cDNA copy of the P1 coding
egion was generated using reverse transcriptase and
he reverse primer 59-CTGGGATCCGAGCTCTTA TT-
ACTGAATCTAGCTCTTGCCTC-39 (underlined sequence
omplementary to TVMV RNA residues 925–948), fol-
owed by PCR amplification with forward primer 59-
CCTCGAGAAACCATGGCAACCATTCACTCAG-39 (un-
erlined sequence corresponding to residues 212–226 of
VMV RNA) and the reverse primer. The PCR fragments
ere gel-purified, treated with the Klenow fragment of
NA polymerase I, and ligated into SmaI-digested and
ephosphorylated pBluescript KS2 (Stratagene). Recom-
inant plasmids obtained by transformation of Esche-
ichia coli NM522 cells were used for complete nt se-
uence determination of the inserts with specific oligo-
ucleotide primers.
etection of proteins in transgenic plants by Western
lot analyses
The procedure for testing HC-Pro expression in trans-
enic plants has been described previously (Berger et
l., 1989). Anti-HC-Pro serum was diluted 500-fold for
se. The same procedure was used to analyze the ex-
ression of P1 in transgenic plants. The P1-specific an-
iserum described by Rodrı´guez-Cerezo and Shaw (1991)
as diluted 250-fold.
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